Results 281 to 290 of about 493,465 (339)

The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. [PDF]

Mol Cancer
Zhang C, Guo X, Wang Y, Zhang S, Wang Z.
europepmc   +1 more source

The Functional Topology of Phenylpiperazinium Agonists and Antagonists on the Nicotinic Acetylcholine Receptor Landscape: Pointing the Way for Future Therapeutic Management of Inflammation and Neuropathic Pain. [PDF]

ACS Chem Neurosci
Andleeb H, Gulsevin A, Papke RL.
europepmc   +1 more source

HCAR2 is a novel receptor for heme. [PDF]

Blood Adv
Grunenwald A, Peliconi J, Zarantonello A, Dimitrov JD, Roumenina LT, Merle NS.   +5 more
europepmc   +1 more source

Development of a Novel Method to Quantify Quinolinic Acid in Biological Samples. [PDF]

Int J Tryptophan Res
Tasaka M, Fujigaki H, Sugiura S, Fujigaki S, Ikuno A, Yamamoto Y, Takemura M, Kimura A, Saito K.   +8 more
europepmc   +1 more source

Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells. [PDF]

Diabetes
Hamilton A, Zhang Q, Gao R, Hill TG, Salehi A, Knudsen JG, Draper MB, Johnson PRV, Rorsman P, Tarasov AI.   +9 more
europepmc   +1 more source

Nociceptor α7nAChR activation blunts neuronal HMGB1 release and attenuates inflammation and nociceptive behavior. [PDF]

Mol Med
Yang H, Morgan TS, Petruzzelli S, Hashimoto O, Hepler TD, Tynan A, Chaudhry S, Brines M, Andersson U, Chavan SS, Tracey KJ.   +10 more
europepmc   +1 more source

How Varenicline Works: Identifying Critical Receptor and Ligand-based Interactions

Aiken SG, Fiorito D, Harper M, Pikus G, Underhill J, Murray J, Rawlinson J, O’Donoghue AC, Gotti C, Lummis SCR, Viñas TM, Viscarra F, Bermudez I, Gallagher T, Oliveira ASF.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist

Psychopharmacology, 1995
ABT-418, a novel cholinergic ligand, was reported to possess potent cognitive-enhancing and anxiolytic properties in animal models with reduced side effects (Decker et al. 1994; Garvey et al. 1994) suggesting selectivity of effects. In this study, the binding properties of ABT-418 to [3H]-nicotine sites were evaluated and its pharmacology investigated ...
M. Damaj, K. Creasy, S. Welch, J. Rosecrans, M. Aceto, B. Martin   +5 more
semanticscholar   +3 more sources

Nicotinic Agonists and Psychosis

Current Drug Target -CNS & Neurological Disorders, 2002
Schizophrenia patients have insufficient inhibitory processing of identical paired auditory stimuli. This deficient "auditory gating" is thought to have physiological relevance, and its severity correlates with certain measures of both positive and negative symptoms.
J K, Simosky, K E, Stevens, R, Freedman
openaire   +2 more sources

Effects of nicotinic agonists on the NMDA receptor

Brain Research, 1991
The cholinergic nicotinic agonists (-)nicotine and lobeline were observed to partially inhibit whole-cell N-methyl-D-aspartate (NMDA)-induced responses in rat cortical neurons in culture. In addition we found that (-)nicotine, (+)nicotine, and lobeline, but not the nicotine metabolite (-)cotinine nor acetylcholine, were able to displace [3H]dizocilpine
E, Aizenman, L H, Tang, I J, Reynolds
openaire   +2 more sources